News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
The firm has developed a new classifier for bladder cancer and continues to work with pharma companies in the lung cancer space.
The project will focus on metabolic biomarkers that previous research has linked to heart disease, type 2 diabetes, and other common chronic diseases.
The PMSC, which formally opened last week, offers mass spectrometry and sequencing resources to help customers develop robust and scalable workflows.
As part of the collaboration, Johnson & Johnson will build a lung cancer center at Boston University and build upon programs linked to cancer research.
Microbiotica will use its metagenomics microbiome platform to help Genentech develop biomarkers, targets, and medicines for inflammatory bowel disease.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.
This webinar will discuss an approach for automating variant classification based on the American College of Medical Genetics and Genomics guidelines.
This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.
This webinar will provide an overview of recent advances in single-cell RNA sequencing from the perspectives of three research organizations.